Koppikar Utpal 4
4 · Atara Biotherapeutics, Inc. · Filed Feb 9, 2023
Insider Transaction Report
Form 4
Koppikar Utpal
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-02-07$5.46/sh−2,485$13,568→ 188,849 total
Footnotes (1)
- [F1]Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.